Company Bioclinic Srl with Fiscal Code 13118220
recorded a turnover of 2024 of
110.772,
with a net profit of
51.870
and having an average number of employees of
1.
The company operates in the field of Intermedieri în comerţul cu maşini, echipamente industriale, nave şi avioane having the NACE code 4614.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Bioclinic Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
50.087
41.209
37.801
38.104
56.310
49.865
22.333
15.729
95.761
110.772
Total Income - EUR
50.699
41.906
38.920
38.115
56.364
49.867
22.333
15.729
95.779
110.781
Total Expenses - EUR
28.198
17.150
24.637
29.546
27.178
15.963
16.141
27.387
40.866
56.086
Gross Profit/Loss - EUR
22.501
24.756
14.284
8.569
29.186
33.903
6.193
-11.658
54.913
54.695
Net Profit/Loss - EUR
20.993
23.518
13.820
8.188
28.622
33.411
5.974
-11.807
53.975
51.870
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 16.3%, from 95.761 euro in the year 2023, to 110.772 euro in 2024.
The Net Profit decreased by -1.803 euro, from 53.975 euro in 2023, to 51.870 in the last year.
Check the financial reports for the company - Bioclinic Srl
Financial Rating - BIOCLINIC SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Bioclinic Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Bioclinic Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Bioclinic Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
88.980 euro in 2024 which includes Inventories of
0 euro, Receivables of
10.236 euro and cash availability of
78.744 euro.
The company's Equity was valued at
89.265 euro, while total Liabilities amounted to
2.662 euro.
Equity increased by 27.832 euro, from 61.778 euro in 2023, to 89.265 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Bioclinic Srl